“Friends or foes”: a new perspective of tumour metabolic transcriptional modification DOI Creative Commons
Tong Shi,

Qishun Geng,

Zhaoran Wang

et al.

Cell Death and Disease, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 17, 2025

Abstract Energy metabolism plays a pivotal role in cancer clinical treatment and has become an important means of diagnosis tumour progression. However, current research mostly focuses on changes metabolic products neglects the deeper mechanisms transcriptional regulation. This paper proposes new perspective, establishing comprehensive network that reveals interaction between transcription, which explores how affects progression through modifications, provides novel approach for optimizing strategies. viewpoint is conducive to overcoming bottlenecks promoting development drug combinations personalized medicine.

Language: Английский

Glucose metabolism is controlled by non-coding RNAs in autoimmune diseases; a glimpse into immune system dysregulation DOI
Raed Obaid Saleh,

Raed Fanoukh Aboqader Al-Aouadi,

Nujud Almuzaini

et al.

Human Immunology, Journal Year: 2025, Volume and Issue: 86(3), P. 111269 - 111269

Published: Feb. 24, 2025

Language: Английский

Citations

1

“Friends or foes”: a new perspective of tumour metabolic transcriptional modification DOI Creative Commons
Tong Shi,

Qishun Geng,

Zhaoran Wang

et al.

Cell Death and Disease, Journal Year: 2025, Volume and Issue: 16(1)

Published: Feb. 17, 2025

Abstract Energy metabolism plays a pivotal role in cancer clinical treatment and has become an important means of diagnosis tumour progression. However, current research mostly focuses on changes metabolic products neglects the deeper mechanisms transcriptional regulation. This paper proposes new perspective, establishing comprehensive network that reveals interaction between transcription, which explores how affects progression through modifications, provides novel approach for optimizing strategies. viewpoint is conducive to overcoming bottlenecks promoting development drug combinations personalized medicine.

Language: Английский

Citations

0